[Postinfarction statins. An unquestionable benefit. A therapeutic strategy that can be improved]

¹Servei de Cardiologia, Hospital General Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, España. egalveb@meditex.es

|April 6, 2002

Summary

Statins significantly reduce cardiovascular events and mortality after myocardial infarction. Ongoing research explores their pleiotropic effects, optimal timing, and dosage for improved patient outcomes.

Area of Science:

Cardiovascular Medicine
Pharmacology

Context:

Atherosclerotic disease is linked to hypercholesterolemia.
Statins represent a highly effective class of lipid-lowering drugs.

Purpose:

To review the established benefits of statins post-myocardial infarction.
To identify and discuss unresolved questions regarding statin therapy in this patient population.

Summary:

Three major trials confirm statins reduce cardiovascular events and mortality after myocardial infarction.
Key areas for further research include statins' pleiotropic effects, optimal treatment initiation timing, target lipid levels, and appropriate dosage.

Impact:

Statins are a cornerstone of post-myocardial infarction care.
Further research aims to refine statin utilization for enhanced survival and quality of life in survivors.

Related Experiment Videos

[Postinfarction statins. An unquestionable benefit. A therapeutic strategy that can be improved]

Related Concept Videos

Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban.

Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.

Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.

E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.

A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention.

Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease.

[Initial experience with the implementation of an interdisciplinary clinic for the follow-up of pediatric patients with single ventricle].

[Anesthesia in carcinoid syndrome for tricuspid and pulmonary valve replacement: case report].

Intimal sarcoma of the heart and great vessels: clinicopathologic series with imaging and immunohistochemistry correlation.

Outcomes of thoracic endovascular aortic repair. 10-years follow-up in LATAM population: experience from a tertiary care center in Mexico.

Real-world outcomes of tafamidis in transthyretin amyloid cardiomyopathy.

Floating aortic arch thrombus revealing an occult ascending aortic dissection: a case report.

Mitochondrial Omics in Macrophage Foam Cell Formation and Atherosclerosis.

Discordance between symptomatic, echocardiographic and renal trajectories after SGLT2 inhibitor initiation in heart failure: a landmark analysis of the prospective CaRD registry.

Dynamic Prognostic Value of IL-6/PLT Ratio for Mortality Discrimination in Patients With Crimean-Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course: IL-6/PLT Ratio for Mortality Discrimination in CCHF.

Dual percutaneous management of Dunning type III iatrogenic aortic dissection during percutaneous coronary intervention: a case report.

Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy.

Impact of calcium administration on survival and neurologic outcomes in adults with in-hospital cardiac arrest.

Related Experiment Videos

[Postinfarction statins. An unquestionable benefit. A therapeutic strategy that can be improved]

Area of Science:

Context:

Purpose:

Summary:

Impact:

Related Concept Videos

Related Articles